FDYNX
Price
$157.12
Change
-$0.21 (-0.13%)
Updated
Aug 15 closing price
Net Assets
28.44B
VIGRX
Price
$237.87
Change
-$0.79 (-0.33%)
Updated
Aug 15 closing price
Net Assets
324.3B
Interact to see
Advertisement

FDYNX vs VIGRX

Header iconFDYNX vs VIGRX Comparison
Open Charts FDYNX vs VIGRXBanner chart's image
Franklin DynaTech C
Price$157.12
Change-$0.21 (-0.13%)
VolumeN/A
Net Assets28.44B
Vanguard Growth Index Investor
Price$237.87
Change-$0.79 (-0.33%)
VolumeN/A
Net Assets324.3B
FDYNX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FDYNX vs. VIGRX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDYNX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 324B vs. FDYNX (28.4B). VIGRX pays higher dividends than FDYNX: VIGRX (0.32) vs FDYNX (0.00). FDYNX was incepted earlier than VIGRX: FDYNX (29 years) vs VIGRX (33 years). FDYNX (1.54) is less costly to investors than VIGRX (0.17). FDYNX is a more actively managed with annual turnover of: 11.94 vs. VIGRX (11.00). FDYNX has a lower initial minimum investment than VIGRX: FDYNX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 24.03 vs. FDYNX (21.48). VIGRX return over 5 years is better than : 107.21 vs. FDYNX (64.35).
FDYNXVIGRXFDYNX / VIGRX
Total Expense Ratio1.540.17906%
Annual Report Gross Expense Ratio1.540.17906%
Fund Existence29 years33 years-
Gain YTD13.58312.580108%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets28.4B324B9%
Annual Yield % from dividends0.000.32-
Returns for 1 year21.4824.0389%
Returns for 3 years67.1073.6891%
Returns for 5 years64.35107.2160%
Returns for 10 years256.60321.5180%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR27.260.57
+2.14%
Nektar Therapeutics
SUPN42.690.52
+1.23%
Supernus Pharmaceuticals
FTAI144.72-0.18
-0.12%
FTAI Aviation Ltd
SBFM1.49-0.02
-1.33%
Sunshine Biopharma Inc
AXTI2.05-0.11
-5.09%
AXT